Outcomes and toxicities of triple metronomic chemotherapy with low-dose nivolumab and axitinib in unresectable, recurrent, and metastatic head-and-neck squamous cell carcinomas: A real-world retrospective analysis from a resource-constrained setting
Background: This study aimed to evaluate whether the addition of an anti-vascular endothelial growth factor (VEGF) agent, axitinib, to oral metronomic chemotherapy and low-dose nivolumab could improve survival outcomes without increasing toxicities in patients with advanced, unresectable, or metasta...
Shranjeno v:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer Medknow Publications
2026-01-01
|
| Serija: | Cancer Research, Statistics, and Treatment |
| Teme: | |
| Online dostop: | https://journals.lww.com/crst/fulltext/2026/01000/outcomes_and_toxicities_of_triple_metronomic.5.aspx |
| Oznake: |
Brez oznak, prvi označite!
|